Search for Novo Nordisk AS and
  1. September 14, 2014

    Novo Nordisk says US more open to obesity drugs

    US regulators are becoming more open to drugs for tackling obesity, says the chief executive of Novo Nordisk, as the Danish...

  2. May 1, 2014

    Novo Nordisk ends streak of double-digit quarterly growth

    Novo Nordisk failed to post quarterly double-digit sales growth for the first time in 12 years, bringing to an end one of...

Special Reports

  1. Combating Diabetes

    With the number of cases predicted to reach 592m worldwide by 2013, tackling the condi...
Search more Special Reports on this topic.

  1. April 1, 2014

    Bristol-Myers Squibb: side effects

    One of these things is not like the others, as Big Bird sings. Look at the mega-cap pharma and biotech stocks. In the near...

  2. March 27, 2014

    Baxter: own devices

    Once you’ve played the trump card, what do you do with the rest of your hand? That’s a question Baxter International’s...

  3. March 27, 2014

    Novo Nordisk joins fight against diabetes epidemic in cities

    Novo Nordisk is to team up with some of the world’s biggest cities to find ways of tackling diabetes, amid warnings that the...

  4. January 3, 2014

    Buy China and Scandinavia, sell France and Turkey

    Like almost everyone else, I’m cautiously optimistic about prospects for 2014. I think we’re in the fairly early stages of a...

  5. December 10, 2013

    Novo Nordisk reported to police over disclosure delay on ruling

    Novo Nordisk has been reported to the police by the Danish Financial Supervisory Authority for failing to disclose critical...

  6. November 14, 2013

    Drug manufacturers seek to expand the range of treatments

    Three companies have long dominated the commercial battle over insulin. For nearly a century since it was first developed,...

  7. November 14, 2013

    Diabetes sufferers seek injection of effort

    When Paul Zimmet first conducted research on the island of Nauru nearly four decades ago, he was shocked to find that a...

  8. November 14, 2013

    Universal availability of insulin yet to be achieved

    There are fewer than nine years to go before the centenary of insulin’s introduction in 1922, but David Beran is not ready...

  9. November 7, 2013

    Novo Nordisk faces headwinds to remain biggest Nordic group

    What is the biggest company in the Nordic region? Measured by market capitalisation, it is not AP Møller-Maersk or Ericsson,...

  10. August 22, 2013

    Eli Lilly drawn into pharmaceutical corruption claims in China

    Eli Lilly became the latest western pharmaceutical group to be drawn into escalating allegations of corruption in China,...

  11. August 11, 2013

    Comparing drug prices across borders a difficult task

    Comparing the prices of medicines across borders is an intellectual challenge for academics, a profitable business for...

  12. August 8, 2013

    Novo Nordisk raises forecasts amid demand for diabetes treatments

    Novo Nordisk, the Nordic region’s most valuable company by market capitalisation, raised its sales and profit guidance for...

  13. August 8, 2013

    Chinese drugs industry inquiry widens

    Three more western pharmaceutical companies have been drawn into widening Chinese probes into pricing and marketing...

  14. July 18, 2013

    Belgian pharma group in China probe

    UCB has become the latest focus of inquiries by Chinese officials in a growing clampdown on drug pricing and marketing...

  15. May 1, 2013

    Novo Nordisk/Lundbeck: drugs start working

    The news from Denmark’s sizeable pharmaceuticals sector has been suitably Nordic noir recently. H Lundbeck, beset by patent...

  16. April 15, 2013

    Healthcare bucks sell-off in Europe

    Heathcare was the most sought after sector on Monday amid a wider sell-off on global growth concerns that led to European...

  17. February 15, 2013

    Renault drives on from dire 2012

    Renault convinced investors this week that it had turned a corner after a dire 2012. The French carmaker said it had a net...

  18. February 11, 2013

    Novo Nordisk ails after drug ruling

    News that Novo Nordisk , the Danish drugs company, failed to win approval for a new drug triggered a strong response from...

  19. February 11, 2013

    Novo Nordisk: reality check

    There goes the visibility premium. Novo Nordisk has stood out from rivals in recent years because its growth has been so...

  20. February 11, 2013

    FDA rejects Novo Nordisk insulin remedy

    Novo Nordisk lost DKr80bn from its stock market value after the Danish drugs company failed to win US regulatory approval...

  21. January 8, 2013

    Novo Nordisk rises amid Denmark high

    Denmark’s index of leading blue-chip companies reached an all-time high on Tuesday. Copenhagen’s OMX 20 climbed 0.8 per cent...

  22. December 26, 2012

    Pharma groups hope for diet drugs binge

    As Christmas overeating gives way to under-fulfilled new year diets, the pharmaceutical industry’s appetite has been whetted...

  23. November 18, 2012

    Novo Nordisk becomes largest Nordic group

    Novo Nordisk has become the largest company in the Nordic region by market capitalisation, overtaking Norway’s Statoil,...

  24. November 16, 2012

    SAS survival hangs on crew pay deal

    The future of SAS is hanging in the balance after management issued an ultimatum this week to force pilots and cabin crew to...

  25. November 9, 2012

    Banks drive European equities lower

    Crédit Agricole capped a difficult week for European banks on Friday as the French lender reported a wider than expected net...

  26. October 31, 2012

    Novo Nordisk raises profit guidance

    Novo Nordisk has become one of the rare European companies to raise its profit guidance for the year, as the Danish drugs...

  27. October 4, 2012

    France’s bruiser disrupts Sanofi’s recovery

    The French language does not, I think, contain a verb that means “to mug a well-known company”. How about montebourger?...

  28. July 1, 2012

    BMS / Amylin

    Bad habits equal big opportunities. As the world’s population gets fatter, diabetes is on the rise. The World Health...

  29. March 28, 2012

    Amylin jumps 50% on talk of failed bid

    Shares in Amylin Pharmaceuticals rose more than 50 per cent on Wednesday on reports of a spurned $3.5bn takeover bid for the...

  30. February 5, 2012

    Pharma seeks to ease pain of euro crisis

    With Greece and Spain struggling to repay billions of euros in outstanding debts to the healthcare sector as the eurozone...

  31. January 22, 2012

    Food groups angry at obesity campaign

    Graphic marketing campaigns intended to frighten people about obesity are drawing fire from US beverage and restaurant...

  32. beyondbrics

    December 6, 2011

    Merck bets big on China

    For all the news of growth slowdowns, drug companies still love EMs. Merck, the US pharmaceutical giant, announced on...

  33. December 5, 2011

    A model for healthier profits

    When Poul Rasmussen is asked to justify the unusual governance structure of Leo Pharma, the Danish pharmaceutical group, he...

  34. beyondbrics

    December 5, 2011

    Pharma still bullish on EMs

    By Mark Wembridge With the slowdown in the developed world hitting healthcare spending,  pharmaceuticals companies are...

  35. October 31, 2011

    Sustainability lessons from the boardroom

    By Sarah Murray In one of his finance and sustainability classes at Columbia Business School, Bruce Usher likes to talk...

  36. FT Alphaville

    October 27, 2011

    Snap news

    Breaking pre-market news on Thursday, - BoJ eases policy, boosts asset buying fund – statement. - Royal Dutch Shell Q3 CCS...

  37. October 12, 2011

    Design space: A smart cap for insulin pens

    Product: Timesulin “smart cap” Designed: In-house Territory: Worldwide About 366m people suffer from diabetes, and about 27...

  38. September 11, 2011

    Novo Nordisk

    The decision to build a grandiose new corporate headquarters is too often an indicator that crisis is ahead; look at Time...

Search for Novo Nordisk AS and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Rising insulin sales boost growth at Danish pharma group...
    September 14, 2014

    Rising insulin sales boost growth at Danish pharma group

  2. Lex on Novo Nordisk's failure to win approval on insulin drug...
    February 11, 2013

    Lex on Novo Nordisk's failure to win approval on insuli...